Tu Thomas's Form 4 filing
Inari Medical, Inc. (NARI) · filed Aug 18, 2023
- Accession no.
- 0001127602-23-022958
- Filed
- Aug 18, 2023
- Trade date
- Aug 16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.65M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tu ThomasCIK 0001806426 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Common Stock | SSaleDisposed | −12,346 | $65.31 | −$806,317.26 | 360,577 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −5,443 | $66.32 | −$360,979.76 | 355,134 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −6,732 | $67.31 | −$453,130.92 | 348,402 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −405 | $68.03 | −$27,552.15 | 347,997 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.